Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Ofloxacin - OFLO

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (64)

Subject

  • Clarithromycin - CLARI (15)
  • Dapsone (6)
  • Preventive Chemotherapy (PC) (1)
  • Minocycline - MINO (23)
  • Moxifloxacin (6)
  • (-) Ofloxacin - OFLO (65)
  • Rifampicin - RMP (26)
  • Rifapentine - RPT (3)
  • Multi-drug therapy (MDT) (14)
  • Complications and reactions (1)
  • Diagnosis (1)
  • Treatment (24)
  • Drug resistance (18)

Publication Type

  • Article (60)
  • Dissertation / Thesis (1)
  • Full text online (34)
  • Letter to the editor (2)

Journal

  • Acta leprologica (1)
  • American journal of clinical and experimental medicine (1)
  • Anais brasileiros de dermatologia (1)
  • Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (1)
  • Antimicrobial agents and chemotherapy (6)
  • Arzneimittel-Forschung (1)
  • Bulletin de la Societe de pathologie exotique (1990) (1)
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1)
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (1)
  • Clinical pharmacology : advances and applications (1)
  • Computational and structural biotechnology journal (1)
  • European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • Indian journal of leprosy (4)
  • Internal medicine (Tokyo, Japan) (1)
  • International journal of antimicrobial agents (1)
  • International journal of dermatology (4)
  • International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (6)
  • JAMA (1)
  • Journal of cutaneous medicine and surgery (1)
  • Journal of global antimicrobial resistance (3)
  • Journal of the Indian Medical Association (1)
  • Journal of the Medical Association of Thailand = Chotmaihet thangphaet (1)
  • Lancet (London, England) (1)
  • Leprosy review (8)
  • Medecine tropicale : revue du Corps de sante colonial (1)
  • Microbial drug resistance (Larchmont, N.Y.) (1)
  • Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association (2)
  • Pharmacotherapy (1)
  • PLOS Neglected Tropical Diseases (1)
  • Revista da Sociedade Brasileira de Medicina Tropical (2)
  • Serbian Journal of Dermatology and Venereology (1)
  • The American journal of tropical medicine and hygiene (1)
  • The Journal of infection (1)
  • The National medical journal of India (1)
  • Tropical Medicine & International Health (1)

Year of Publication

  • 2022 (3)
  • 2021 (2)
  • 2020 (5)
  • 2019 (2)
  • 2018 (1)
  • 2017 (3)
  • 2016 (1)
  • 2015 (1)
  • 2013 (1)
  • 2012 (2)
  • 2011 (2)
  • 2010 (2)
  • 2008 (2)
  • 2007 (1)
  • 2006 (2)
  • 2005 (2)
  • 2004 (1)
  • 2003 (2)
  • 2002 (1)
  • 2001 (2)
  • 2000 (4)
  • 1999 (1)
  • 1998 (2)
  • 1997 (4)
  • 1996 (4)
  • 1995 (3)
  • 1994 (3)
  • 1992 (3)
  • 1987 (1)
  • 1986 (1)

Language

  • English (54)
  • French (3)
  • Japanese (2)
  • Portuguese (3)
  • Russian (1)

Regional focus

  • Benin (1)
  • Burkina Faso (1)
  • Ethiopia (1)
  • European Region (EUR) (2)
    • France (2)
  • Guinea (1)
  • Madagascar (1)
  • Mali (1)
  • Mozambique (1)
  • Niger (1)
  • Pakistan (1)
  • Region of the Americas (AMR) (6)
    • Brazil (6)
    • Colombia (1)
    • USA (1)
  • South-East Asia Region (SEAR) (6)
    • India (6)
    • Indonesia (2)
    • Myanmar (1)
    • Nepal (2)
  • Western Pacific Region (WPR) (1)
    • China (1)
    • Korea, South – Republic of Korea (1)
    • Philippines (1)
    • Vietnam (1)
  • Yemen (1)
 
  • Relevance
  • Date
65 items

Publication

Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases.

Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022;
Download PDF

Publication

Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.

Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022;

Publication

Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme.

Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022;
Download PDF

Publication

Interaction of Quinolones Carrying New R1 Group with DNA Gyrase.

Park J, Yamaguchi T, Ouchi Y, et al. Microbial drug resistance (Larchmont, N.Y.). 2021;
Download PDF

Publication

Validação de modelo murino para avaliação da atividade antibacteriana de ofloxacina e clofazimina contra o Mycobacterium leprae

Rocha AF. Instituto Lauro de Souza Lima. 2021;

Publication

HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae..

Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020;
Download PDF

Publication

Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.

Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020;
Download PDF

Publication

Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.

Faust L, Klowak M, MacRae C, et al. Journal of cutaneous medicine and surgery. 2020;

Publication

Treatment of histoid leprosy: a lack of consensus.

Bartos G, Sheuring R, Combs A, et al. International journal of dermatology. 2020;

Publication

Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse.

Kamat D, Narang T, Ahuja M, et al. The American journal of tropical medicine and hygiene. 2020;

Publication

Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports

Widjaja Y, Djawad K, Amin S, et al. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 89-93.
Download PDF

Publication

Development of an Assay System for Genotyping Mycobacterium leprae Resistant to Dapsone, Rifampicin, and Ofloxacin

Tanod V, Bela B, Menaldi S, et al. Indian journal of leprosy. 2019; 91 (3) : 185-195.
Download PDF

Publication

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-2015.

Cambau E, Saunderson P, Matsuoka M, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018;
Download PDF

Publication

Interleukin-12 and Interleukin-4 Levels of Multibacillary Leprosy Patients Before and After Rifampicine Ofloxacine Minocycline Combined Therapy

Budhiani S, Muchtar SV, Amin S. American journal of clinical and experimental medicine . 2017; 5 (4) : 134-137.
Download PDF

Publication

Molecular detection of multi drug resistant Mycobacterium leprae from Indian leprosy patients.

Lavania M, Singh I, Turankar R, et al. Journal of global antimicrobial resistance. 2017;
Download PDF

Publication

Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study.

Guragain S, Upadhayay N, Bhattarai BM. Clinical pharmacology : advances and applications. 2017;
Download PDF

Publication

Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy

Joseph P, Ponnaiya J, Das M, et al. Indian journal of leprosy. 2016;
Download PDF

Publication

A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.

Kumar A, Girdhar A, Girdhar BK. Indian journal of dermatology, venereology and leprology. 2015; 81 (4) : 356-62.
Download PDF

Publication

Resistance of M. leprae to Quinolones: A Question of Relativity?

Veziris N, Chauffour A, Escolano S, et al. PLOS Neglected Tropical Diseases. 2013;
Download PDF

Publication

OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil

Souza Cunha MG, Virmond M, Schettini AP, et al. Leprosy review. 2012; 83 (3) : 261–268.
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD